Literature DB >> 21112109

Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build on.

Nataliya Razumilava1, Gregory J Gores.   

Abstract

Entities:  

Year:  2010        PMID： 21112109     DOI： 10.1016/j.jhep.2010.10.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  9 in total

Review 1.  [Diagnostics and treatment of cholangiocellular carcinoma].

Authors:  L Zender; N P Malek
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

Review 2.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

3.  Reversal of jaundice in two patients with inoperable cholangiocarcinoma treated with Cisplatin and gemcitabine combination.

Authors:  Maarten Criel; Filip Geurs; Siegfried Ponette; Katrien Bulte; Johan Ponette
Journal:  Case Reports Hepatol       Date:  2012-03-20

Review 4.  Recent Advances in Understanding Cholangiocarcinoma.

Authors:  Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Nicole Francis; Rowan Seils; Sara Villamaria; Heather Francis
Journal:  F1000Res       Date:  2017-10-09

5.  Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.

Authors:  Ying-Chen Xu; Jing Cui; Li-Jun Zhang; Dong-Xin Zhang; Bing-Chen Xing; Xiong-Wei-Ye Huang; Ji-Xiang Wu; Chao-Jie Liang; Guang-Ming Li
Journal:  Chin Med J (Engl)       Date:  2018-01-05       Impact factor: 2.628

6.  miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.

Authors:  Jingbang Wu; Beng Yang; Yanpeng Zhang; Xiaode Feng; Bin He; Haiyang Xie; Lin Zhou; Jian Wu; Shusen Zheng
Journal:  Int J Biol Sci       Date:  2019-06-04       Impact factor: 6.580

7.  Establishment and verification of potential biomarkers for cholangiocarcinoma.

Authors:  Shuai Wang; Leilei Yu; Xiangyu Sun; Bo Zhang
Journal:  Exp Ther Med       Date:  2022-06-30       Impact factor: 2.751

8.  A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma.

Authors:  Tiziana Palumbo; George A Poultsides; Grigorios Kouraklis; Theodore Liakakos; Alexandra Drakaki; George Peros; Maria Hatziapostolou; Dimitrios Iliopoulos
Journal:  BMC Cancer       Date:  2016-06-03       Impact factor: 4.430

Review 9.  The new insight of treatment in Cholangiocarcinoma.

Authors:  Yuhang Li; Yinghui Song; Sulai Liu
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.